Warrants (Details - Warrant activity) - Warrant [Member] - $ / shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Warrants outstanding at beginning balance | 25,734,752 | |
| Weighted-average remaining contractual life | 2 years 10 months 6 days | 1 year 1 month 28 days |
| Weighted-average exercise price per share at beginning balance | $ 2.19 | |
| Warrants outstanding, granted | 0 | |
| Warrants outstanding, exercised | (1,462,000) | |
| Weighted-average exercise price per share, exercised | $ 0.01 | |
| Warrants outstanding, expired | (121,809) | |
| Weighted-average exercise price per share, expired | $ 3.60 | |
| Warrants outstanding, forfeitures | 0 | |
| Warrants outstanding at ending balance | 24,150,943 | |
| Weighted-average exercise price per share at ending balance | $ 2.32 | |
| Weighted-average remaining contractual life, exercisable | 2 years 10 months 6 days | |
| Weighted-average exercise price per share, exercisable | $ 2.32 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|